Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
about
MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled StudiesC2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.Transmembrane mucins as novel therapeutic targetsThe role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized MedicinePrognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.Detection of disseminated tumor cells in peripheral blood.Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissueDevelopment and progression of colorectal neoplasia.Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists allianceMUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significanceClinical use of biomarkers of survival in pulmonary fibrosis.Cell surface markers in colorectal cancer prognosis.Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.TG4010: a vaccine with a therapeutic role in cancer.Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis.Clinical significance of type V(I) pit pattern subclassification in determining the depth of invasion of colorectal neoplasmsImmunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.Clinical Impact of the KL-6 Concentration of Pancreatic Juice for Diagnosing Pancreatic Masses.Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.MUC expression in adenosquamous carcinoma of the head and neck regions of Japanese patients: immunohistochemical analysis.Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
P2860
Q26787178-BFD2D1FA-B321-46C6-B960-5F80B954BF1FQ33809540-2D101918-01EB-44DC-9D26-4B147912EC31Q33821277-E0333D18-76C7-490F-A75F-F38A00FDBE2CQ33829875-37CCFD4B-45F4-4F21-8F4B-11C95D091BDEQ34032146-6700C592-C9BE-42B4-856D-D52A44B6EC67Q34501563-4E19DF3F-8D56-4855-9E5A-FEF9BC769C59Q34627201-80297823-5E81-4DA1-A52F-DDFFEBDA28BBQ35059595-71D86ECD-D117-48B1-BCD3-E28601A3D4D7Q35632645-C5D6DD36-993F-4A83-B1B4-C922FA6AC853Q35689819-8CE3C13E-8949-4964-A482-ED552C40789FQ35909577-EC2B1836-3218-4647-81E9-1493745E41A6Q36014430-8E45FF11-4526-4332-8448-17985FDB1398Q36154564-92D430D2-37F8-4E3F-85CD-7A049F2DAA3CQ36190339-A1827EDE-FC78-45EC-96A7-79E1E661AC4EQ36241935-7570E331-4DB1-4D56-8B86-4D4E8AE7F173Q36457087-7EA90A6D-9B81-4475-AF3B-E75A34780225Q37222803-5705BF2F-2B67-4DC6-9A13-C70DE11845EAQ37768235-1CA72613-34A1-4BC2-BF2E-0ABA2CD7277DQ37845669-8C0A5377-29B7-4EB8-9CFB-258522C2DBA8Q38216010-C9247D7A-AA30-4455-B908-87EAAD96C616Q38332313-4211563B-9DD4-4FED-9C87-618170E11FADQ38366747-E18B9BB9-2F6D-4B8E-8B8F-DC79D76F11CFQ38824172-D215B123-2A19-4DB2-BE68-811E311B7E84Q41557414-5965DF0A-7466-407B-9506-5450DE22B2E1Q41833115-CFF131CC-0422-4990-B0F4-39C7DA7F5740Q41852083-40904B58-579E-4A19-AC0B-83F2F953DCD8Q42179576-682ADBB3-5980-4E55-BE6C-7FB56AC3495AQ43923444-34B6F503-7A2C-4B15-9D4B-4D864814D650Q44523503-C35A78CB-12F8-4758-B40B-AC539C35A07BQ53059430-F0B1AA99-FCEA-4037-A699-BB4BD03E8F2AQ54477932-901624E4-C4EA-4AA5-B84B-477DEE624E4D
P2860
Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@en
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@nl
type
label
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@en
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@nl
prefLabel
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@en
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@nl
P2093
P356
P1433
P1476
Immunoreactive MUC1 expression ...... rognosis of colorectal cancer.
@en
P2093
Kajiyama G
Shimamoto F
Yoshihara M
P304
P356
10.1159/000011868
P577
1998-07-01T00:00:00Z